Dynamics Group AG | WebDisclosure

Basculer en Français

10562	Companies
223495	Keywords
152500	Articles
118268	Press releases

Home
Companies
Dynamics Group AG

PRESS RELEASE

published on 02/05/2026 at 07:30, 4 months 9 days ago

Lithuania Selects Procivis for the National European Digital Identity Wallet Sandbox
Lithuania selects Procivis to provide EUDI Wallet sandbox, facilitating digital identity activities and readiness for EU-wide launch. Procivis One technology ensures secure interoperability and regulatory alignment

Digital Identity Sandbox Lithuania Procivis EUDI Wallet
BRIEF

published on 01/02/2026 at 08:05, 5 months 12 days ago

Frédéric Prince nommé PDG de Neovii Pharmaceuticals

Transition Du PDG Changement De Leadership Neovii Pharmaceuticals Frédéric Prince Perte Chrétienne
BRIEF

published on 01/02/2026 at 08:05, 5 months 12 days ago

Frédéric Prince to Lead Neovii Pharmaceuticals as New CEO

CEO Transition Leadership Change Neovii Pharmaceuticals Frédéric Prince Christian Loss
PRESS RELEASE

published on 01/02/2026 at 08:00, 5 months 12 days ago

CEO transition at Neovii Pharmaceuticals: Frédéric Prince to succeed Christian Loss, effective January 1st, 2026
Frédéric Prince to succeed Christian Loss as CEO of Neovii Pharmaceuticals on January 1st, 2026. Dr. Loss retires after distinguished career. Dr. Prince brings extensive experience in research & development and commercial functions

CEO Transition Leadership Roles Neovii Pharmaceuticals Frédéric Prince Christian Loss
BRIEF

published on 12/24/2025 at 13:03, 5 months 21 days ago

DiNABIOS se félicite de l'adoption de la loi de modernisation de la FDA 3.0

Innovation Développement De Médicaments DiNABIOS Modernisation De La FDA Nouvelles Méthodologies D'approche
BRIEF

published on 12/24/2025 at 13:03, 5 months 21 days ago

DiNABIOS Welcomes FDA Modernization Act 3.0 Passage

Innovation Drug Development FDA Modernization DiNABIOS New Approach Methodologies
PRESS RELEASE

published on 12/24/2025 at 12:58, 5 months 21 days ago

DiNABIOS Applauds Historic U.S. Senate Passage of FDA Modernization Act 3.0, Advancing Human‑Relevant New Approach Methodologies (NAMs)
DiNABIOS celebrates U.S. Senate passage of FDA Modernization Act 3.0, promoting human-relevant NAMs for drug development and reducing animal testing

Drug Development DiNABIOS FDA Modernization Act 3.0 NAMs Animal Testing
BRIEF

published on 12/23/2025 at 14:41, 5 months 22 days ago

DiNAQOR présente une plateforme révolutionnaire pour l'administration de médicaments de précision.

Biotechnologie Thérapie Génique Médecine De Précision DiNAQOR Perfusion Loco-régionale
BRIEF

published on 12/23/2025 at 14:41, 5 months 22 days ago

DiNAQOR Introduces Breakthrough Platform for Precision Drug Delivery

Biotechnology Precision Medicine Gene Therapy DiNAQOR Loco-Regional Perfusion
PRESS RELEASE

published on 12/23/2025 at 14:36, 5 months 22 days ago

DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies
DiNAQOR and academic partners introduce groundbreaking percutaneous platform for organ-specific delivery of advanced therapies, addressing critical challenges in gene and cell therapy development

Advanced Therapies DiNAQOR Academic Partners Percutaneous Platform Organ-specific Delivery

Accesswire

Published on 06/13/2026 at 04:50, 1 day 22 hours ago

BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 2 days 1 hour ago

Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 2 days 4 hours ago

BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 2 days 5 hours ago

Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 2 days 12 hours ago

Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders

View all ACCESSWIRE

EQS Group

Published on 06/14/2026 at 14:50, 12 hours 53 minutes ago

Zug voters say yes to Metalli development plan
Published on 06/14/2026 at 13:30, 14 hours 13 minutes ago

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Published on 06/14/2026 at 10:42, 17 hours ago

LightOn Demonstrates the Flexibility of Its OCR Model by Adapting It to Arabic Through Targeted Training.
Published on 06/13/2026 at 08:18, 1 day 19 hours ago

EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 2 days 2 hours ago

OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe

Les Echos

Published on 06/12/2026 at 18:31, 2 days 9 hours ago

Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 17:45, 2 days 9 hours ago

Engagements de conservation d’actions (Pacte Dutreil)
Published on 06/12/2026 at 16:19, 2 days 11 hours ago

SMTPC - Communiqué sur la Reconduite des mandats du Président et du Directeur général
Published on 06/12/2026 at 12:56, 2 days 14 hours ago

SIEHM-Avis de convocation à l'Assemblée Générale Extraordinaire du 30 juin 2026
Published on 06/12/2026 at 12:35, 2 days 15 hours ago

SFCMC - Avis de convocation à l'Assemblée Générale Extraordinaire du 30 juin 2026

View all LES ECHOS COMFI WIRE